Author:
von Essen R.,Uebis R.,Schmidt W.,Dörr R.,Merx W.,Meyer J.,Effert S.,Schweizer P.,Erbel R.,Bardos P.,Minale C.,Messmer B. J.
Reference36 articles.
1. Aber CP, Bas NM, Berry CL, Carson PHM, Dobbs RJ, Fox KM, Hamblin JJ, Haydu SP, Howitt G, MacIver JE, Portal RW, Raftery EB, Rousell RH, Stock JPP (1976) Streptokinase in acute myocardial infarction. A controlled multicentre study in the United Kingdom. Br Med J 2:1100
2. Amery A, Roeber G, Vermeulen HJ, Verstraete M (1969) Single-blind randomized multicentre trial comparing heparin and streptokinase treatment in recent myocardial infarction. Acta Med Scand 505 (Suppl):5
3. Bett JHN, Castaldi PA, Chesterman CN, Hale GS, Hirsh J, Isbister JP, McDonald IG, McLean KH, Morgan JJ, O’Sullivan EF, Rosenbaum M (1973) Australian multicentre trial of streptokinase in acute myocardial infarction. Lancet I:57
4. Boucek RJ, Murphy WP Jr, Sommer LS, Voudoukis IJ (1960) Segmental perfusion of the coronary arteries with fibrinolysin in man following a myocardial infarction. Am J Cardiol 6:525
5. Breddin K, Ehrly AM, Fechler L, Frick D, König H, Kraft H, Krause H, Krywanek HJ, Kutschera J, Lösch HW, Ludwig O, Mikat B, Rausch F, Rosenthal P, Sartory S, Voigt G (1973) Die Kurzzeitfibrinolyse beim akuten Myokardinfarkt. Dtsch Med Wschr 98:861